Reporting of clinical trials of analgesia.
Katz
Nathaniel
N
D000698:Analgesia / Q000379:methods*; D016058:Analgesia, Patient-Controlled; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007527:Isoenzymes / Q000008:administration & dosage* / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D007555:Isoxazoles / Q000008:administration & dosage* / Q000009:adverse effects; D008565:Membrane Proteins; D009020:Morphine / Q000008:administration & dosage; D011451:Prostaglandin-Endoperoxide Synthases / Q000008:administration & dosage* / Q000009:adverse effects; D013449:Sulfonamides / Q000008:administration & dosage* / Q000009:adverse effects
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D007555:Isoxazoles; D008565:Membrane Proteins; D013449:Sulfonamides; D009020:Morphine; C409945:parecoxib; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases